Difference between revisions of "OncoMouse"
From Cyborg Anthropology
Caseorganic (Talk | contribs) |
Caseorganic (Talk | contribs) |
||
| Line 2: | Line 2: | ||
===Definition=== | ===Definition=== | ||
| − | OncoMouse is both a noun and a trademark. It is a term used to describe a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.<ref>New Oxford American Dictionary | + | OncoMouse is both a noun and a trademark. It is a term used to describe a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.<ref>New Oxford American Dictionary</ref> OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref> |
| − | + | Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University designed the mouse to carry an activated oncogene, a specific gene that significantly increases the mouse’s susceptibility to cancer. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref> | |
==References== | ==References== | ||
| Line 10: | Line 10: | ||
[[Category:Book Pages]] | [[Category:Book Pages]] | ||
| − | [[Category: | + | [[Category:Finished]] |
Revision as of 02:45, 6 November 2011
Definition
OncoMouse is both a noun and a trademark. It is a term used to describe a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.[2]
Philip Leder and Timothy A Stewart[3] of Harvard University designed the mouse to carry an activated oncogene, a specific gene that significantly increases the mouse’s susceptibility to cancer. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[4]
References
- ↑ New Oxford American Dictionary
- ↑ U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.
- ↑ European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
- ↑ Trademark: USPTO serial number 75797027
